参考文献/References:
[1] WU S,GUO D,WEI H,YIN X,ZHANG L,GUO B,et al.Disrupted potassium ion homeostasis in ciliary muscle in negative lens-induced myopia in guinea pigs[J].Arch Biochem Biophys,2020,688:108403.
[2] HAN X,LIU C,CHEN Y,HE M.Myopia prediction:a systematic review[J].Eye,2022,36(5):921-929.
[3] TANO Y.Pathologic myopia:where are we now?[J].Am J Ophthalmol,2002,134(5):645-660.
[4] HSIANG H W,OHNO-MATSUI K,SHIMADA N,HAYASHI K,MORIYAMA M,YOSHIDA T,et al.Clinical characteristics of posterior staphyloma in eyes with pathologic myopia[J].Am J Ophthalmol,2008,146(1):102-110.
[5] WITKOVSKY P.Dopamine and retinal function[J].Doc Ophthalmol,2004,108(1):17-40.
[6] FELDKAEMPER M,SCHAEFFEL F.An updated view on the role of dopamine in myopia[J].Exp Eye Res,2013,114:106-119.
[7] NEBBIOSO M,PLATEROTI A M,PUCCI B,PESCOSOLIDO N.Role of the dopaminergic system in the development of myopia in children and adolescents[J].J Child Neurol,2014,29(12):1739-1746.
[8] DARRINGTON E,ZHONG M,VO B H,KHAN S A.Vascular endothelial growth factor A,secreted in response to transforming growth factor-β1 under hypoxic conditions,induces autocrine effects on migration of prostate cancer cells[J].Asian J Androl,2012,14(5):745-751.
[9] THEIS V,THEISS C.VEGF:a stimulus for neuronal development and regeneration in the CNS and PNS[J].Curr Protein Pept Sci,2018,19(6):589-597.
[10] TIAN Y Y,TANG C J,WANG J N,FENG Y,CHEN X W,WANG L,et al.Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors[J].Neurosci Lett,2007,421(3):239-244.
[11] YASUHARA T,SHINGO T,KOBAYASHI K,TAKEUCHI A,YANO A,MURAOKA K,et al.Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson’s disease[J].Eur J Neurosci,2004,19(6):1494-1504.
[12] YASUHARA T,SHINGO T,MURAOKA K,YUAN W J,KAMEDA M,TAKEUCHI A,et al.The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson’s disease model[J].Brain Res,2005,1038(1):1-10.
[13] YASUHARA T,SHINGO T,MURAOKA K,KAMEDA M,AGARI T,YUAN W J,et al.Neurorescue effects of VEGF on a rat model of Parkinson’s disease[J].Brain Res,2005,1053(1/2):10-18.
[14] 邱宇,高洪莲,于睿,李欣蒙,崔钰莹,张磊.抗血管内皮生长因子玻璃体内注射对形觉剥夺性近视豚鼠视网膜中多巴胺水平的影响[J].眼科新进展,2022,42(2):113-117.
QIU Y,GAO H L,YU R,LI X M,CUI Y Y,ZHANG L.Effect of intravitreal injection of anti-vascular endothelial growth factor on the dopamine level in the retina of guinea pigs with form deprivation myopia[J].Rec Adv Ophthalmol,2022,42(2):113-117.
[15] SARFARE S,YANG J,NICKLA D L.The effects of brief high intensity light on ocular growth in chicks developing myopia vary with time of day[J].Exp Eye Res,2020,195:108039.
[16] CHEN P,XU L,ZHANG J,CAI X,YANG Y,YU J,et al.Up-regulation of SorCS1,an important sorting receptor,in the retina of a form-deprivation rat model[J].Cell Mol Neurobiol,2020,40(3):395-405.
[17] CHAKRABORTY R,YANG V,PARK H N,LANDIS E G,DHAKAL S,MOTZ C T,et al.Lack of cone mediated retinal function increases susceptibility to form-deprivation myopia in mice[J].Exp Eye Res,2019,180:226-230.
[18] WANG M,SCHAEFFEL F,JIANG B,FELDKAEMPER M.Effects of light of different spectral composition on refractive development and retinal dopamine in chicks[J].Invest Ophthalmol Vis Sci,2018,59(11):4413-4424.
[19] KLEIN M O,BATTAGELLO D S,CARDOSO A R,HAUSER D N,BITTENCOURT J C,CORREA R G.Dopamine:functions,signaling,and association with neurological diseases[J].Cell Mol Neurobiol,2019,39(1):31-59.
[20] SANKARAN M,KEELEY P W,HE L,IUVONE P M,REESE B E.Dopaminergic amacrine cell number,plexus density,and dopamine content in the mouse retina:strain differences and effects of Bax gene disruption[J].Exp Eye Res,2018,177:208-212.
[21] MATHIS U,FELDKAEMPER M,WANG M,SCHAEFFEL F.Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken[J].Graefes Arch Clin Exp Ophthalmol,2020,258(2):319-333.
[22] CHIA A,CHUA W H,CHEUNG Y B,WONG W L,LINGHAM A,FONG A,et al.Atropine for the treatment of childhood myopia:safety and efficacy of 0.5%,0.1%,and 0.01% doses (Atropine for the Treatment of Myopia 2)[J].Ophthalmology,2012,119(2):347-354.
[23] SIATKOWSKI R M,COTTER S A,CROCKETT R S,MILLER J M,NOVACK G D,ZADNIK K.Two-year multicenter,randomized,double-masked,placebo-controlled,parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia[J].J AAPOS,2008,12(4):332-339.
[24] MENG X Y,HUANG A Q,KHAN A,ZHANG L,SUN X Q,SONG H,et al.Vascular endothelial growth factor-loaded poly-lactic-co-glycolic acid nanoparticles with controlled release protect the dopaminergic neurons in Parkinson’s rats[J].Chem Biol Drug Des,2020,95(6):631-639.
[25] 崔钰莹,邱宇,高洪莲,张磊.抗血管内皮生长因子对氧诱导视网膜新生血管病变模型小鼠视网膜多巴胺含量的影响[J].眼科新进展,2022,42(6):440-445.
CUI Y Y,QIU Y,GAO H L,ZHANG L.Effect of anti-vascular endothelial growth factor on retinal dopamine content in mice with oxygen-induced retinopathy[J].Rec Adv Ophthalmol,2022,42(6):440-445.